Routinely, in conversations about the disparities in cancer care between black and white patients, and the fact that black patients continue to experience worse outcomes, the same trite phrase inevitably comes up: “Oh, it’s because of their genes.” This sentiment—that…
Men who undergo androgen deprivation therapy (ADT) for prostate cancer (PCa) are at elevated risk of developing non-alcoholic fatty liver disease and other liver diseases, a study found. Compared with PCa patients who did not receive ADT, those who did…
The headline read, "Dental care before cancer surgery might be good idea." An intriguing concept, one that warranted a closer look. But learning more and more about the results of a recently-released study, the more confounders, underwhelming data and limitations…
Patients undergoing major cancer surgery might reduce their risk of complications by seeing a dentist beforehand, a study from Japan suggests. Patients who visited a dentist were slightly less likely to have post-surgery pneumonia or die within 30 days of…
The Brigham Innovation Hub connects the hospital community to the right resources to implement digital health projects that could benefit patients. After hearing about a mobile app project in the works by urologist Quoc-Dien Trinh, MD, Elias reached out to…
The story was all too familiar. A patient is diagnosed with locally aggressive prostate cancer. A few days before the surgery, the patient does not show up for his preoperative visit. We call the patient. “We noticed you didn’t show…
After U.S. guidelines advised against routine tests, declines in prostate cancer screening have been sharper among primary care doctors than urologists, according to a new study that suggests the medical community remains divided over the best way to look for…
NETWORKED “SMART” devices are poised to revolutionize health care, from infusion pumps that provide essential safety checks for the medications they deliver to multimillion-dollar robots that allow for more precise surgery and Bluetooth-connected pacemakers. But with these new opportunities come…
Black men with riskier prostate cancers may be less likely than their white counterparts to get aggressive treatment that can give them the best survival odds, a recent U.S. study suggests. Researchers focused on men with medium- and high-risk localized…
An influential physician task force backed by the U.S. government is softening its opposition to routine prostate cancer screening. In proposed guidelines released today, the U.S. Preventive Services Task Force advised men aged 55 to 69 to discuss the pros…